Airdoc 鹰瞳科技 vs Wysa
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Airdoc 鹰瞳科技
HK-listed AI retinal screening for eye and chronic-disease risk
Visit
|
Wysa
FDA Breakthrough-designated AI mental health companion delivering CBT...
Visit
|
|
|---|---|---|
| RECATOOLS Score | 6.8 / 10 | 7.8 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Freemium |
| Free tier | — | Core AI companion, limited CBT/DBT sessions, mood tracking — no credit card required |
| Paid from | — | Premium ~USD 29.99/month; Enterprise custom pricing |
| Has API | ✗ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✓ |
| Users | — | 6 million+ users; 500 million+ conversations across 95 countries |
| Founded | — | 2015 |
| Maker | — | Touchkin eServices Private Limited |
| Verdict | A single retinal photo, read by Airdoc's model in about three minutes, is enough to flag diabetic retinopathy and eight other chronic-disease risk indicators alongside 35 named eye conditions — a genuinely differentiated... |
An FDA Breakthrough Device Designation from May 2022 puts Wysa in rare company among consumer mental-health apps — regulatory validation, not just wellness-app marketing. NHS data backs it up: 31 Talking Therapies servic... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.